NeoGenomics, Inc. (NASDAQ:NEO) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Lynn Tetrault ??? Interim CEO Charlie Eidson ??? Director of Investor Relations Bill Bonello ??? Chief Financial Officer Chris Smith ??? Incoming Chief Executive Officer David Sholehvar ??? President, Clinical Division Vishal Sikri ??? President, Pharma Services Division and President-Inivata Conference Call Participants Brian Weinstein ??? William Blair Alex Nowak ??? Craig-Hallum David Westenberg ...

NeoGenomics, Inc. (NASDAQ:NEO) Q1 2022 Earnings Conference Call April 27, 2022 8:30 AM ET Company Participants Lynn Tetrault - Executive Chair & Principal Executive Officer William Bonello - Chief Financial Officer Doug Brown - Chief Strategy and Corporate Development Officer Charlie Eidson - Director, Investor Relations Shashi Kulkarni - Chief Scientific Officer David Sholehvar - Clinical Division President Conference Call Participants Brian Weinstein - William Blair Matt Sykes - Goldman Sachs Andrew Coope ...

| --- | --- | --- | --- | --- | --- | |-----------------------|-------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Investor Presentation | NeoGenomics | | | | | | April 2022 | | | | | | Forward-Looking Statements This presentation has been prepared by NeoGenomics, Inc. ("we," "us," "our," "NeoGenomics" or the "Company") and is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy s ...

| --- | --- | --- | --- | --- | |-------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | NeoGenomics Investor Presentation | | | | | | February 2022 | | | | | Forward‐Looking Statements This presentation has been prepared by NeoGenomics, Inc. ("we," "us," "our," "NeoGenomics" or the "Company") and is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities, nor shall there be any sale of ...

NeoGenomics Inc. (NASDAQ:NEO) Q4 2021 Earnings Conference Call February 23, 2022 8:30 AM ET Company Participants Mark Mallon - Chief Executive Officer William Bonello - Chief Financial Officer Clive Morris - President, Inivata George Cardoza - President, Chief Operating Officer Gina Waller - President, Pharma Services Clynt Taylor - President, Informatics Charlie Eidson - Director, Investor Relations Conference Call Participants Brian Weinstein - William Blair Mark Massaro - BTIG Alex Nowak - Craig Hallum P ...

NeoGenomics Conference Call Prepared Remarks Good morning. I'd like to welcome everyone to NeoGenomics' 2021 Third Quarter conference call. Joining me for this call from our new headquarters in Fort Myers are George Cardoza, President and Chief Operating Officer of our Lab Operations, Doug Brown, our Chief Strategy and Corporate Development Officer and Charlie Eidson, our Director of Investor Relations. Joining on the call via phone from California is Dr. Gina Wallar, President of our Pharma Services Divisi ...

NeoGenomics, Inc. (NASDAQ:NEO) Q3 2021 Earnings Conference Call November 4, 2021 8:30 AM ET Company Participants Mark Mallon - Chief Executive Officer George Cardoza - President, Lab Operations and COO Doug Brown - Chief Strategy and Corporate Development Officer Charlie Eidson - Director, Investor Relations Dr. Gina Wallar - President, Pharma Services Division Dr. Clive Morris - President, Inivata Kathryn McKenzie - Chief Financial Officer Bill Bonello - President, Informatics Conference Call Participants ...

NeoGenomics, Inc. (NASDAQ:NEO) Q2 2021 Earnings Conference Call August 6, 2021 8:30 AM ET Company Participants Doug VanOort - Chairman Mark Mallon - CEO Kathryn McKenzie - CFO George Cardoza - President, Pharma Services Division Bill Bonello - President, Informatics Division Doug Brown - Chief Strategy and Corporate Development Officer Clive Morris - CEO, Inivata Conference Call Participants David Westenberg - Guggenheim Brian Weinstein - William Blair Alex Nowak - Craig-Hallum Capital Group Mark Massaro - ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------------------|-------|-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | NeoGenomics Investor Presentation | | | | | | | | | | May 2021 | | | | | | | | | 1 and and and the see and 2 Forward-Looking Statements This presentation has been prepared by NeoGenomics, Inc. ("we," "us," "our," "NeoGenomics" or the "Company") and is made for informational purposes only and does not constitute an offer to sell or ...

NeoGenomics, Inc. (NASDAQ:NEO) Q1 2021 Earnings Conference Call May 5, 2021 8:30 AM ET Company Participants Doug VanOort - Chairman Mark Mallon - Chief Executive Officer Kathryn McKenzie - Chief Financial Officer George Cardoza - President, Pharma Services Division Bill Bonello - President, Informatics Division Doug Brown - Chief Strategy and Corporate Development Officer Charlie Eidson - Manager of Investor Relations Clive Morris - Chief Executive Officer, Inivata Conference Call Participants Puneet Souda ...